{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:58:41Z","timestamp":1790294321782,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00507256"],"award-info":[{"award-number":["RS-2024-00507256"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00516722"],"award-info":[{"award-number":["RS-2025-00516722"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2022-NR070845"],"award-info":[{"award-number":["RS-2022-NR070845"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Animuscure Inc"},{"name":"Animuscure Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02935-7","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:01:55Z","timestamp":1790290915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inotodiol prevents age-related muscle wasting by restoring mitochondrial function through liver X receptor beta signaling"],"prefix":"10.1038","volume":"11","author":[{"given":"Chang-Lim","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1638-6820","authenticated-orcid":false,"given":"Ju-Hyeon","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yideul","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Eun","family":"Leem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan Anh","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwoong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Sam","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moongi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Jeong","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-2415","authenticated-orcid":false,"given":"IL-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4625-4957","authenticated-orcid":false,"given":"Gyu-Un","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Sun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"2935_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.7861\/clinmedicine.16-5-455","volume":"16","author":"R Dodds","year":"2016","unstructured":"Dodds, R. & Sayer, A. A. Sarcopenia and frailty: new challenges for clinical practice. Clin. Med. 16, 455\u2013458 (2016).","journal-title":"Clin. Med."},{"key":"2935_CR2","doi-asserted-by":"publisher","first-page":"155533","DOI":"10.1016\/j.metabol.2023.155533","volume":"144","author":"S Yuan","year":"2023","unstructured":"Yuan, S. & Larsson, S. C. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism 144, 155533 (2023).","journal-title":"Metabolism"},{"key":"2935_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000517099","volume":"68","author":"J Xu","year":"2022","unstructured":"Xu, J., Wan, C. S., Ktoris, K., Reijnierse, E. M. & Maier, A. B. Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology 68, 361\u2013376 (2022).","journal-title":"Gerontology"},{"key":"2935_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/geroni\/igae098.1954","volume":"8","author":"W Evans","year":"2024","unstructured":"Evans, W. Sarcopenia: no consensus, no diagnostic criteria, and no approved indication how did we get here? Innov. Aging 8, 597\u2013597 (2024).","journal-title":"Innov. Aging"},{"key":"2935_CR5","doi-asserted-by":"publisher","first-page":"156565","DOI":"10.1016\/j.metabol.2023.155597","volume":"149","author":"Y Rolland","year":"2023","unstructured":"Rolland, Y., Dray, C., Vellas, B. & Barreto, P. D. Current and investigational medications for the treatment of sarcopenia. Metab. Clin. Exp. 149, 156565 (2023).","journal-title":"Metab. Clin. Exp."},{"key":"2935_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116539","volume":"164","author":"A Al Saedi","year":"2022","unstructured":"Al Saedi, A., Debruin, D. A., Hayes, A. & Hamrick, M. Lipid metabolism in sarcopenia. Bone 164, 116539 (2022).","journal-title":"Bone"},{"key":"2935_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13098-023-01022-z","volume":"15","author":"ZJ Liu","year":"2023","unstructured":"Liu, Z. J. & Zhu, C. F. Causal relationship between insulin resistance and sarcopenia. Diabetol. Metab. Syndr. 15, 46 (2023).","journal-title":"Diabetol. Metab. Syndr."},{"key":"2935_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109221","volume":"27","author":"LY Wang","year":"2024","unstructured":"Wang, L. Y., Valencak, T. G. & Shan, T. Z. Fat infiltration in skeletal muscle: influential triggers and regulatory mechanism. iScience 27, 109221 (2024).","journal-title":"iScience"},{"key":"2935_CR9","doi-asserted-by":"publisher","first-page":"8179","DOI":"10.3390\/ijms22158179","volume":"22","author":"JP Leduc-Gaudet","year":"2021","unstructured":"Leduc-Gaudet, J. P., Hussain, S. N. A., Barreiro, E. & Gouspillou, G. Mitochondrial dynamics and mitophagy in skeletal muscle health and aging. Int. J. Mol. Sci. 22, 8179 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2935_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fphys.2015.00422","volume":"6","author":"V Romanello","year":"2016","unstructured":"Romanello, V. & Sandri, M. Mitochondrial quality control and muscle mass maintenance. Front. Physiol. 6, 422 (2016).","journal-title":"Front. Physiol."},{"key":"2935_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s41048-015-0013-0","volume":"1","author":"Y Li","year":"2015","unstructured":"Li, Y., Xu, S., Zhang, X., Yi, Z. & Cichello, S. Skeletal intramyocellular lipid metabolism and insulin resistance. Biophys. Rep. 1, 90\u201398 (2015).","journal-title":"Biophys. Rep."},{"key":"2935_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.70000","volume":"16","author":"SY Jang","year":"2025","unstructured":"Jang, S. Y. & Choi, K. M. Impact of adipose tissue and lipids on skeletal muscle in sarcopenia. J. Cachexia Sarcopenia Muscle 16, e70000 (2025).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2935_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12944-025-02622-6","volume":"24","author":"DW Russ","year":"2025","unstructured":"Russ, D. W., Manickam, R. & Tipparaju, S. M. Targeting intramyocellular lipids to improve aging muscle function. Lipids Health Dis. 24, 197 (2025).","journal-title":"Lipids Health Dis."},{"key":"2935_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/oby.2006.47","volume":"14","author":"VB Schrauwen-Hinderling","year":"2006","unstructured":"Schrauwen-Hinderling, V. B., Hesselink, M. K., Schrauwen, P. & Kooi, M. E. Intramyocellular lipid content in human skeletal muscle. Obesity 14, 357\u2013367 (2006).","journal-title":"Obesity"},{"key":"2935_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13694-1","volume":"10","author":"E Migliavacca","year":"2019","unstructured":"Migliavacca, E. et al. Mitochondrial oxidative capacity and NAD(+) biosynthesis are reduced in human sarcopenia across ethnicities. Nat. Commun. 10, 5808 (2019).","journal-title":"Nat. Commun."},{"key":"2935_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13105-024-01062-7","volume":"81","author":"NT Kamarulzaman","year":"2025","unstructured":"Kamarulzaman, N. T. & Makpol, S. The link between mitochondria and sarcopenia. J. Physiol. Biochem. 81, 1\u201320 (2025).","journal-title":"J. Physiol. Biochem."},{"key":"2935_CR17","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.biocel.2013.06.024","volume":"45","author":"E Marzetti","year":"2013","unstructured":"Marzetti, E. et al. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int. J. Biochem. Cell B. 45, 2288\u20132301 (2013).","journal-title":"Int. J. Biochem. Cell B."},{"key":"2935_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14107","volume":"240","author":"C Affourtit","year":"2024","unstructured":"Affourtit, C. & Carr\u00e9, J. E. Mitochondrial involvement in sarcopenia. Acta Physiol. 240, e14107 (2024).","journal-title":"Acta Physiol."},{"key":"2935_CR19","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.2337\/db12-1650","volume":"62","author":"EX Jing","year":"2013","unstructured":"Jing, E. X. et al. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 62, 3404\u20133417 (2013).","journal-title":"Diabetes"},{"key":"2935_CR20","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.2337\/db14-1810","volume":"64","author":"L Lantier","year":"2015","unstructured":"Lantier, L. et al. SIRT3 is crucial for maintaining skeletal muscle insulin action and protects against severe insulin resistance in high-fat-fed mice. Diabetes 64, 3081\u20133092 (2015).","journal-title":"Diabetes"},{"key":"2935_CR21","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/antiox12051075","volume":"12","author":"O Abu Shelbayeh","year":"2023","unstructured":"Abu Shelbayeh, O., Arroum, T., Morris, S. & Busch, K. B. PGC-1alpha is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxidants 12, 1075 (2023).","journal-title":"Antioxidants"},{"key":"2935_CR22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1139\/apnm-2020-0005","volume":"45","author":"JF Halling","year":"2020","unstructured":"Halling, J. F. & Pilegaard, H. PGC-1alpha-mediated regulation of mitochondrial function and physiological implications. Appl. Physiol. Nutr. Metab. 45, 927\u2013936 (2020).","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"2935_CR23","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.3390\/cells11162596","volume":"11","author":"L Zhou","year":"2022","unstructured":"Zhou, L., Pinho, R., Gu, Y. & Radak, Z. The role of SIRT3 in exercise and aging. Cells 11, 2596 (2022).","journal-title":"Cells"},{"key":"2935_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1474-9726.2012.00844.x","volume":"11","author":"AM Joseph","year":"2012","unstructured":"Joseph, A. M. et al. The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals. Aging Cell 11, 801\u2013809 (2012).","journal-title":"Aging Cell"},{"key":"2935_CR25","doi-asserted-by":"publisher","first-page":"E157","DOI":"10.1152\/ajpendo.00578.2013","volume":"306","author":"S Sczelecki","year":"2014","unstructured":"Sczelecki, S. et al. Loss of Pgc-1alpha expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation. Am. J. Physiol. Endocrinol. Metab. 306, E157\u2013E167 (2014).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2935_CR26","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1073\/pnas.0501559102","volume":"102","author":"KR Short","year":"2005","unstructured":"Short, K. R. et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc. Natl. Acad. Sci. USA. 102, 5618\u20135623 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2935_CR27","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1096\/fj.03-1341fje","volume":"18","author":"C Guillet","year":"2004","unstructured":"Guillet, C. et al. Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans. FASEB J. 18, 1586\u20131587 (2004).","journal-title":"FASEB J."},{"key":"2935_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","volume":"14","author":"B Wang","year":"2018","unstructured":"Wang, B. & Tontonoz, P. Liver X receptors in lipid signaling and membrane homeostasis. Nat. Rev. Endocrinol. 14, 452\u2013463 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2935_CR29","doi-asserted-by":"publisher","first-page":"E602","DOI":"10.1152\/ajpendo.00553.2009","volume":"298","author":"NP Hessvik","year":"2010","unstructured":"Hessvik, N. P. et al. LXR\u03b2 is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux. Am. J. Physiol. Endocrinol. Metab. 298, E602\u2013E613 (2010).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2935_CR30","doi-asserted-by":"publisher","first-page":"E167","DOI":"10.1152\/ajpendo.00184.2009","volume":"298","author":"M Korach-Andr\u00e9","year":"2010","unstructured":"Korach-Andr\u00e9, M. et al. Separate and overlapping metabolic functions of LXR\u03b1 and LXR\u03b2 in C57Bl\/6 female mice. Am. J. Physiol. Endocrinol. Metab. 298, E167\u2013E178 (2010).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2935_CR31","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1110\/ps.04951405","volume":"14","author":"LD Yue","year":"2005","unstructured":"Yue, L. D. et al. Ligand-binding regulation of LXR\/RXR and LXR\/PPAR heterodimerizations: SPR technology-based kinetic analysis correlated with molecular dynamics simulation. Protein Sci. 14, 812\u2013822 (2005).","journal-title":"Protein Sci."},{"key":"2935_CR32","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1194\/jlr.R400010-JLR200","volume":"45","author":"AC Li","year":"2004","unstructured":"Li, A. C. & Glass, C. K. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J. Lipid Res. 45, 2161\u20132173 (2004).","journal-title":"J. Lipid Res."},{"key":"2935_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nrd4280","volume":"13","author":"C Hong","year":"2014","unstructured":"Hong, C. & Tontonoz, P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat. Rev. Drug Discov. 13, 433\u2013444 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2935_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/14728222.2022.2117610","volume":"26","author":"SR Savla","year":"2022","unstructured":"Savla, S. R., Prabhavalkar, K. S. & Bhatt, L. K. Liver X receptor: a potential target in the treatment of atherosclerosis. Expert Opin. Ther. Tar. 26, 645\u2013658 (2022).","journal-title":"Expert Opin. Ther. Tar."},{"key":"2935_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111333","volume":"224","author":"AA Abulaban","year":"2025","unstructured":"Abulaban, A. A. et al. Role of liver X receptor in multiple sclerosis: a long furtive life behind a barrier. Brain Res. Bull. 224, 111333 (2025).","journal-title":"Brain Res. Bull."},{"key":"2935_CR36","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.7150\/ijbs.84970","volume":"19","author":"CL You","year":"2023","unstructured":"You, C. L. et al. Inonotus obliquus upregulates muscle regeneration and augments function through muscle oxidative metabolism. Int. J. Biol. Sci. 19, 4898\u20134914 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"2935_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.stem.2023.03.016","volume":"30","author":"L Liu","year":"2023","unstructured":"Liu, L. et al. Exercise reprograms the inflammatory landscape of multiple stem cell compartments during mammalian aging. Cell Stem Cell 30, 689\u2013705.e4 (2023).","journal-title":"Cell Stem Cell"},{"key":"2935_CR38","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.4161\/cc.29272","volume":"13","author":"R Troncoso","year":"2014","unstructured":"Troncoso, R. et al. Dexamethasone-induced autophagy mediates muscle atrophy through mitochondrial clearance. Cell Cycle 13, 2281\u20132295 (2014).","journal-title":"Cell Cycle"},{"key":"2935_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2024.112615","volume":"198","author":"CC Sun","year":"2024","unstructured":"Sun, C. C. et al. Establishment of a dexamethasone-induced zebrafish skeletal muscle atrophy model and exploration of its mechanisms. Exp. Gerontol. 198, 112615 (2024).","journal-title":"Exp. Gerontol."},{"key":"2935_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04369-z","volume":"21","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Mitochondrial dysfunction: roles in skeletal muscle atrophy. J. Transl. Med. 21, 503 (2023).","journal-title":"J. Transl. Med."},{"key":"2935_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101966","volume":"89","author":"WD Arnold","year":"2023","unstructured":"Arnold, W. D. & Clark, B. C. Neuromuscular junction transmission failure in aging and sarcopenia: the nexus of the neurological and muscular systems. Aging Res. Rev. 89, 101966 (2023).","journal-title":"Aging Res. Rev."},{"key":"2935_CR42","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s11357-021-00510-2","volume":"44","author":"A Moreira-Pais","year":"2022","unstructured":"Moreira-Pais, A., Ferreira, R., Oliveira, P. A. & Duarte, J. A. A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved. Geroscience 44, 1199\u20131213 (2022).","journal-title":"Geroscience"},{"key":"2935_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117895","volume":"184","author":"SY Ban","year":"2025","unstructured":"Ban, S. Y. et al. Liver-X receptor beta-selective agonist CE9A215 regulates Alzheimer\u2019s disease-associated pathology in a 3xTg-AD mouse model. Biomed. Pharmacother. 184, 117895 (2025).","journal-title":"Biomed. Pharmacother."},{"key":"2935_CR44","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1371\/journal.pbio.0020294","volume":"2","author":"YX Wang","year":"2004","unstructured":"Wang, Y. X. et al. Regulation of muscle fiber type and running endurance by PPAR\u03b4. PLoS Biol. 2, 1532\u20131539 (2004).","journal-title":"PLoS Biol."},{"key":"2935_CR45","doi-asserted-by":"publisher","first-page":"e85636","DOI":"10.1371\/journal.pone.0085636","volume":"9","author":"LG Lin","year":"2014","unstructured":"Lin, L. G. et al. Regulation of skeletal muscle oxidative capacity and muscle mass by SIRT3. PLoS One 9, e85636 (2014).","journal-title":"PLoS One"},{"key":"2935_CR46","doi-asserted-by":"publisher","first-page":"771","DOI":"10.18632\/aging.100075","volume":"1","author":"OM Palacios","year":"2009","unstructured":"Palacios, O. M. et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1\u03b1 in skeletal muscle. Aging-Us 1, 771\u2013783 (2009).","journal-title":"Aging-Us"},{"key":"2935_CR47","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1042\/BJ20110702","volume":"437","author":"PW Caton","year":"2011","unstructured":"Caton, P. W., Holness, M. J., Bishop-Bailey, D. & Sugden, M. C. PPAR\u03b1-LXR as a novel metabolostatic signaling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status. Biochem J. 437, 521\u2013530 (2011).","journal-title":"Biochem J."},{"key":"2935_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1458-8","volume":"10","author":"L Tong","year":"2019","unstructured":"Tong, L. et al. PPAR\u03b4 attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation. Cell Death Dis. 10, 197 (2019).","journal-title":"Cell Death Dis."},{"key":"2935_CR49","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.3390\/molecules27154704","volume":"27","author":"TMN Nguyen","year":"2022","unstructured":"Nguyen, T. M. N. et al. Evaluation of toxicity and efficacy of inotodiol as an anti-inflammatory agent using animal model. Molecules 27, 4704 (2022).","journal-title":"Molecules"},{"key":"2935_CR50","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1111\/bph.15286","volume":"178","author":"J Bu\u00f1ay","year":"2021","unstructured":"Bu\u00f1ay, J. et al. Screening for liver X receptor modulators: where are we and for what use? Brit J. Pharm. 178, 3277\u20133293 (2021).","journal-title":"Brit J. Pharm."},{"key":"2935_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh3489","volume":"15","author":"JH Bae","year":"2023","unstructured":"Bae, J. H. et al. Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate. Sci. Transl. Med. 15, eabh3489 (2023).","journal-title":"Sci. Transl. Med."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02935-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02935-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02935-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:01:57Z","timestamp":1790290917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02935-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2935"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02935-7","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.L.Y., J.H.B., and S.J.L. have filed a patent entitled \u201cCOMPOSITION COMPRISING INOTODIOL FOR PREVENTION OR TREATMENT OF MUSCULAR DISEASE\u201d (PCT\/KR2021\/015026). G.U.B. and J.S.K. are founders of AniMusCure Inc. and hold an ownership equity interest in the company. These arrangements have been reviewed and approved by Sookmyung University (G.U.B.) and Sungkyunkwan University (J.S.K.) in accordance with their conflict of interest policies.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"408"}}